Jonathan Finn
Board Member
Atossa Therapeutics, Inc. (ATOS)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jonathan Finn
Jonathan Finn is recorded as Board Member at Atossa Therapeutics, Inc. (ATOS). Atossa Therapeutics, Inc. reported in an 8-K filed November 9, 2023 that Jonathan Finn was appointed Class I director, effective November 9, 2023.
“On November 9, 2023, Atossa Therapeutics, Inc. (The "Company") issued a press release announcing that Jonathan Finn, CFA, has been appointed to the Company's board of directors, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-11-09–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Atossa Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Steven Quay CEO
- Greg Weaver CFO
- Mark Daniel CFO, Chief Accounting Officer
- Mark J. Daniel CFO
- Dr. Tessa Cigler, M.D., M.P.H. Board Member
- H. Lawrence Remmel, Esq. Board Member
- Jonathan Finn, CFA Board Member
- Shu-Chih Chen Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.